12:00 AM
 | 
Jan 23, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Regnite gabapentin enacarbil regulatory update

XenoPort and Astellas said the Japanese Ministry of Health, Labor and Welfare (MHLW) approved Regnite gabapentin enacarbil to treat moderate to severe restless legs...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >